You are here

Potentiating an Anthrax DNA Vaccine with Electroporation

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 2R44AI052670-02
Agency Tracking Number: AI052670
Amount: $2,634,040.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Timeline
Solicitation Year: 2004
Award Year: 2004
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
6310 NANCY RIDGE DR., STE. 107
SAN DIEGO, CA 92121
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 ALAIN Luxembourg
 (858) 550-2022
 ALUXEMBOURG@ICHORMS.COM
Business Contact
 DREW HANNAMAN
Phone: (858) 550-2022
Email: DHANNAMAN@ICHORMS.COM
Research Institution
N/A
Abstract

DESCRIPTION (provided by applicant): Anthrax, an infectious disease caused by Bacillus anthracis, became a pressing concern because of its potential biowarfare use, most likely via aerosolized anthrax spore dissemination, resulting in deadly inhalation a

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government